Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Raised to Sell at StockNews.com

StockNews.com upgraded shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) to a sell rating in a research note published on Wednesday morning. ATNM has been the subject of several other reports. HSBC began coverage on Actinium Pharmaceuticals in a research report on Wednesday, September 6th. They set a buy rating and a $11.60 price target […]

Related Keywords

California ,United States ,Canada , ,Actinium Pharmaceuticals ,Actinium Pharmaceuticals Company Profile ,Institutional Trading Of Actinium Pharmaceuticals ,News Ratings For Actinium Pharmaceuticals Daily ,Actinium Pharmaceuticals Trading Down ,Actinium Pharmaceuticals Inc ,Quent Capital ,Manufacturers Life Insurance Company ,Royal Bank ,Free Report ,Pharmaceuticals Trading Down ,Get Free Report ,State Teachers Retirement System ,Actinium Pharmaceuticals Daily ,Nyseamerican Atnm ,Atnm ,Medical ,Upgrade ,Stocknews Com ,